clonidine antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-clonidine antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to food safety diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-141-11. BSA-clonidine
2. Anti-clonidine mouse monoclonal antibody
$2709.00
GMP-SMT-141-21. OVA-clonidine
2. Anti-clonidine mouse monoclonal antibody
$2709.00
GMP-SMT-141-31. BSA-clonidine
2. Anti-clonidine human monoclonal antibody
$2709.00
GMP-SMT-141-41. OVA-clonidine
2. Anti-clonidine human monoclonal antibody
$2709.00
GMP-SMT-141-Ag-1BSA-clonidine$756.00
GMP-SMT-141-Ag-2OVA-clonidine$756.00
GMP-SMT-141-Ab-1Anti-clonidine mouse monoclonal antibody$1953.00
GMP-SMT-141-Ab-2Anti-clonidine human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-clonidine

Cat No.GMP-SMT-141-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-clonidine with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-clonidine had been validated with our anti-Hapten antibody Anti-clonidine mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-clonidine

Cat No.GMP-SMT-141-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-clonidine with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-clonidine had been validated with our anti-Hapten antibody Anti-clonidine mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-clonidine mouse monoclonal antibody

Cat No.GMP-SMT-141-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.3-0.5
Products descriptionThe anti-Hapten antibody against hapten clonidine had been validated with our hapten hapten-carrier conjugates BSA-clonidine via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-clonidine human monoclonal antibody

Cat No.GMP-SMT-141-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.3-0.5
Products descriptionThe anti-Hapten antibody against hapten clonidine had been validated with our hapten hapten-carrier conjugates BSA-clonidine via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Biomarker Information


    1. Clonidine in Environmental Research:

    Clonidine (#1) represents a pivotal small molecule that occupies a unique niche in both pharmaceutical applications and environmental research. This chemically classified sympatholytic agent finds its primary utility in the pharmaceutical arena, specifically in the management of hypertension and attention deficit hyperactivity disorder (ADHD). However, its significance is further underscored by its presence in wastewater effluents, prompting a comprehensive examination of its ecological implications.

    Pharmaceutical Context: Clonidine, within the realm of pharmaceuticals, emerges as a cornerstone therapeutic agent renowned for its capacity to reduce blood pressure. This is achieved through its selective interaction with alpha-2 adrenergic receptors in the central nervous system. Additionally, Clonidine serves as a valuable medication for ameliorating the symptoms associated with ADHD. Its mechanism of action in this context involves enhancing prefrontal cortex functioning, manifesting a calming effect, and thereby enhancing the quality of life for individuals grappling with these medically significant conditions.

    Environmental Relevance: In the environmental context, Clonidine occasionally surfaces in environmental samples, particularly within wastewater effluents. This occurrence is primarily attributed to its excretion by individuals undergoing Clonidine medication. Consequently, its presence in the natural environment raises pertinent questions regarding its potential repercussions on aquatic ecosystems, necessitating a thorough examination of its ecological implications.

    Environmental scientists and toxicologists undertake the scrutiny of Clonidine to fathom its impact on aquatic life forms and ecosystems. This involves meticulous investigations into its persistence, mobility, and potential toxicity in aquatic environments. Furthermore, efforts are directed towards the development of strategies for the removal of Clonidine from wastewater treatment processes, thereby mitigating its entry into aquatic ecosystems.

    A comprehensive understanding of Clonidine's behavior and its ecological ramifications assumes a paramount role in the preservation of environmental integrity. Researchers seek to discern the fate and transport of Clonidine in various environmental compartments, including surface waters, sediments, and biota. This knowledge is vital for the formulation of appropriate risk assessment frameworks and the establishment of environmental quality standards.

    2. The Significance of Clonidine Measurement:

    The measurement of Clonidine (#2) carries profound significance for an array of compelling reasons, spanning the domains of environmental protection, pharmaceutical innovation, clinical oversight, and regulatory compliance. Each of these dimensions serves as a cornerstone of Clonidine measurement's multifaceted importance:

    a. Environmental Surveillance: Monitoring Clonidine levels in aquatic systems emerges as a pivotal tool for assessing contamination levels and evaluating the potential ecological hazards that may ensue. Precise measurements empower researchers and environmental authorities to make informed decisions regarding water quality management and the safeguarding of aquatic ecosystems.

    Monitoring extends to various aquatic matrices, including surface water bodies, wastewater effluents, and sediments. This comprehensive surveillance involves the utilization of sophisticated analytical techniques to measure Clonidine concentrations accurately. The data generated from such monitoring efforts facilitates the identification of potential sources of contamination, the assessment of its impact on aquatic biota, and the formulation of strategies for mitigating its adverse effects.

    Researchers also delve into the elucidation of Clonidine's fate and transport in aquatic environments. This involves studying the mechanisms of Clonidine sorption to sediments, its potential for bioaccumulation in aquatic organisms, and the evaluation of its persistence under varying environmental conditions.

    b. Pharmacological Endeavors: Within the pharmaceutical domain, precise measurement of Clonidine assumes a position of paramount importance across multiple facets of drug development, formulation, and quality assurance. Ensuring the accuracy of Clonidine concentrations in pharmaceutical formulations is quintessential for guaranteeing their efficacy and safety for patient usage.

    The pharmaceutical industry relies on stringent quality control measures to ascertain the potency and uniformity of Clonidine-containing medications. Analytical methods such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS) are employed for the quantification of Clonidine in pharmaceutical formulations. This rigorous measurement protocol ensures that each dosage unit of Clonidine medication delivers the intended therapeutic effect and adheres to regulatory specifications.

    Moreover, the precise measurement of Clonidine plays a pivotal role in pharmacokinetic studies. This involves tracking the absorption, distribution, metabolism, and excretion (ADME) of Clonidine in the human body. Such investigations are indispensable for optimizing dosing regimens, understanding pharmacological interactions, and minimizing the risk of adverse drug reactions.

    c. Clinical Oversight: In the clinical arena, measuring Clonidine levels in patients' blood is indispensable for the continual assessment of its therapeutic efficacy and the avoidance of potential side effects or toxicities. This holds particular significance for individuals undergoing Clonidine treatment for conditions like hypertension or ADHD.

    Blood concentration monitoring is instrumental in customizing Clonidine therapy to the specific needs of patients. It allows healthcare practitioners to titrate Clonidine dosage regimens to achieve optimal blood pressure control while minimizing side effects such as dizziness or sedation. Therapeutic drug monitoring (TDM) protocols, encompassing the precise measurement of Clonidine concentrations in blood plasma, enable the adjustment of treatment plans based on individual patient responses.

    Furthermore, Clonidine measurement supports clinical research endeavors aimed at investigating the pharmacokinetics and pharmacodynamics of Clonidine in diverse patient populations. These studies provide valuable insights into the factors influencing Clonidine's therapeutic effects, ultimately enhancing the precision and safety of its clinical utilization.

    d. Regulatory Adherence: Across various regulatory jurisdictions, prescribed limits for Clonidine concentrations in water bodies have been established to preserve environmental well-being. The routine measurement and monitoring of Clonidine levels are pivotal for adhering to these regulatory guidelines and ensuring compliance with environmental protection regulations.

    Analytical laboratories engaged in environmental monitoring employ state-of-the-art techniques, including liquid chromatography-mass spectrometry (LC-MS), gas chromatography-mass spectrometry (GC-MS), and high-performance liquid chromatography (HPLC), to detect and quantify Clonidine in environmental samples. Stringent quality assurance and quality control protocols are applied to ensure the reliability and accuracy of measurement data.

    Additionally, Clonidine measurement underpins the development of environmental risk assessment frameworks. By establishing concentration thresholds and assessing the potential ecological impact of Clonidine, regulatory authorities can implement measures to mitigate contamination and protect sensitive ecosystems.

    In summation, the act of measuring Clonidine carries multifaceted significance, spanning environmental preservation, pharmaceutical innovation, clinical oversight, and regulatory compliance. Precision in measurement equips us with a heightened comprehension of its environmental impact, ensures pharmaceutical safety and efficacy, and safeguards public health and ecological equilibrium. This comprehensive perspective underscores the pivotal role that accurate Clonidine measurement plays in advancing science, protecting ecosystems, and enhancing human well-being.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.